Dr. Kevin Kalinsky covers the gamut of the current treatment landscape for patients with HER2-negative breast cancer, ...
A medical researcher may have erroneously lost hundreds of thousands of dollars in grant money because she was swept up in ...
Clinical research is indeed a data beast. Healthcare organizations are practically drowning in patient information from their studies—everything from vitals to lab results to patient-reported outcomes ...
Doron Therapeutics, a clinical-stage biotechnology company based in Chapel Hill, has received a Regenerative Medicine Advanced Therapy (RMAT) designation from the U.S. Food and Drug Administration ...
Genetic testing is transforming depression treatment by tailoring antidepressants to your DNA for better results and fewer ...
Actimab-A is a humanized anti-CD33 antibody conjugated to Actinium-225 (Ac-225). With its potent alpha-particle payload ...
Multiracial growth impacts clinical trials. Explore challenges in race classification, health disparities, and genomic profiling.
Refractory chronic cough is a cough that persists for over 8 weeks and does not respond to treatment of any underlying cause. Recent randomised trials for refractory chronic cough have shown ...
Gender-affirming hormone treatment for young people with gender dysphoria: where do we go from here?
Child and adolescent gender medicine is currently one of the most heatedly debated fields in medicine. The recent Cass Review ...
Find out what led biotech to a situation where women are underrepresented in clinical trials and how the industry is ...
Scientific literature has increased at a rate of 8-9% annually since 1980, doubling every decade and creating an information ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback